Toolkit
HIV Treatment and Care
PQDx 0144-043-00 WHO
PQDx Public Report
November/2016, version 4.0
PQDx 0033-013-00 WHO
PQ Public Report
July/2016, version 5.0
PQDx 0141-051-00 WHO
PQDx Public Report
April/2017, version 5.0
PQDx 0053-006-00 WHO
PQ Public Report
June/2016, version 2.0
PQDx 0005-005-00
WHO PQDx PR
May/2016, version 3.0
PQDx 0181-031-00
WHO PQ Public Report
March/2017, version 3.0
July 2018
This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United... Nation’s 90-90-90 targets. In particular, the report synthesises the existing and emerging market demand and supply of kits.
The information in this report is intended for manufacturers, donors, national programmes, researchers and other global health stakeholders who are exploring the potential role of HIVST.
more
PQDx 0027-012-00 WHO
PQDx Public Report
May/2017, version 4.0
PQDx 0159-055-00
WHO PQ Public Report
February/2017, version 5.0
PQDx 0198-071-00
WHO PQDx PR
April/2016, version 2.0
Technical Report
AIDS Medicines and diagnostics service
July 2015
Policy Brief.
WHO recommends that pregnant women receive testing for HIV, syphilis and hepatitis B (HBSAg) at least once during pregnancy, preferably in the first trimester.
Dual HIV/syphilis rapid diagnostic tests (RDTs) can be used as the first test for pregnant women as part of antenatal care (...ANC).
These simple tests can be used at the point-of-care and are cost-saving compared to standard testing in ANC. They enable more women to be diagnosed with HIV and syphilis so that they can access treatment and prevent transmission to their children.
more
Technical Report
AIDS Medicines and diagnostics service
September 2016